Search results for "Cervical Cancer"

showing 10 items of 171 documents

Different T-cell Receptor (TCR) Zeta Chain Expression in Cervical Cancer and its Precursor Lesions

2006

OBJECTIVE Cervical cancer is associated with infection of epithelial cells with the human papillomavirus (HPV) type 16 and HPV18. A functional signalling machinery in T-cells is required in order to successfully fight and eradicate HPV16+ transformed epithelial cells. One of the key signalling molecules associated with the T-cell receptor (TCR) is the homodimeric zeta chain molecule. MATERIAL AND METHODS 28 formalin fixed und paraffin embedded samples of cervical tissue with cervical intraepithelial lesions CIN I (n = 3), CIN III (n = 7), invasive cervical carcinoma (CC) (n = 13) and normal cervical tissue (n = 5) has been evaluated for HPV-PCR und zeta chain immunohistochemistry. For immun…

Cervical cancerPathologymedicine.medical_specialtybusiness.industrymedicine.drug_classT-cell receptorReceptors Antigen T-CellMembrane ProteinsUterine Cervical NeoplasmsObstetrics and GynecologyCancerUterine Cervical Dysplasiamedicine.diseaseMonoclonal antibodyPeripheral blood mononuclear cellMolecular biologyMonoclonalmedicineHumansImmunohistochemistryFemaleNeoplasm InvasivenessClone (B-cell biology)businessZentralblatt für Gynäkologie
researchProduct

Darstellung des Blutflusses in den Gebärmutterarterien und im normalen sowie malignen Gebärmuttergewebe mittels einer 2D-Multiphasen-Tagging-Technik

1998

PURPOSE The aim of this pilot study was to evaluate a 2D-STAR technique as a non contrast-enhanced approach to demonstrate the uterine artery and its branches and to assess the cervical uterine blood flow in healthy volunteers and in patients with advanced uterine cervical carcinoma. MATERIALS AND METHODS Seven healthy volunteers (mean age, 29 years) and twenty-two patients (mean age, 52 years) with advanced cancer of the uterine cervix (FIGO IIB-IVA) were prospectively examined by 2D-STAR imaging at different inversion delay times (300 ms-1900 ms) which showed the passage of a blood bolus through normal and malignant tissue of the uterine cervix. RESULTS The uterine artery was well visuali…

Cervical cancerPathologymedicine.medical_specialtymedicine.diagnostic_testbusiness.industryUltrasoundInterventional radiologyBlood flowmedicine.diseaseBolus (medicine)medicine.arteryCarcinomaMedicineRadiology Nuclear Medicine and imagingbusinessNuclear medicineUterine arteryNeuroradiologyDer Radiologe
researchProduct

Socioeconomic factors and cervical cancer mortality in Spain during the period 1989?1997

2002

A study was made of cervical cancer (CC) mortality trends in Spain during the period 1989–1997 at National, Autonomous Community and Provincial levels, in relation to different socioeconomic factors. Data were obtained from the Spanish National Institute of Statistics (Instituto Nacional de Estadistica, INE). The crude mortality rates were age-adjusted using the indirect method and Gross Domestic Product (GDP) as socioeconomic status (SES) indicator. National CC age-adjusted mortality rates have increasing slightly, varying from 3.09 deaths/100,000 women in 1989 to 3.42 in 1996. The highest age-adjusted mortality rates corresponded to Seville, Palencia and Orense, with 4.13, 4.06 and 3.98 c…

Cervical cancerbusiness.industryMortality rateUterine Cervical NeoplasmsObstetrics and GynecologyGeneral Medicinemedicine.diseaseGross domestic productSocioeconomic FactorsRisk FactorsSpainRelative riskmedicineHumansFemaleHuman papillomavirusParity (mathematics)Mortality trendsbusinessSocioeconomic statusDemographyDemographyArchives of Gynecology and Obstetrics
researchProduct

Evidences of cervical cancer stem cells derived from established cell lines.

2010

According to the longstanding “clonal evolution” model of carcinogenesis, cervical carcinoma has long been described as a consequence of unlimited and uncontrolled cellular proliferation conferred by multiple genetic and/or epigenetic mutations that can hit any somatic cells within the tissue. However, in the last few years, accumulating evidence has suggested that the capacity of initiating a tumor, including cervical carcinoma, is rather a unique feature of a small subset of stemlike cells called “cancer stem cells” (CSCs) or “tumor-initiating cells.” CSCs have the exclusive ability to self-renew expanding the CSCs pool, and to maintain the tumor differentiating into the heterogeneous non…

Cervical cancercervical cancer stem CD44 EMTbiologyCell cultureCD44medicinebiology.proteinCancer researchCell BiologyStem cellmedicine.diseaseMolecular BiologyDevelopmental Biology
researchProduct

EP273 A new integrated pre-surgical diagnostic algorithm to define the local extent of disease in women with cervical cancer

2019

Introduction/Background Survival of patients with cervical cancer is strongly associated with the local extent of the primary disease. For this reason, the new FIGO staging system has given greater importance to instrumental investigations in the pre-surgical evaluation. The objective of this study is to develop an integrated diagnostic algorithm, including ultrasound (US), magnetic resonance imaging (MRI) and clinical examination under anaesthesia (CEUA), to better define the local extent of disease in patients with newly diagnosed cervical cancer, using histology as the referring gold standard. Methodology Patients with biopsy proven cervical cancer submitted to primary surgery from Janua…

Cervical cancermedicine.diagnostic_testParametrialbusiness.industryUltrasoundMagnetic resonance imagingPhysical examinationGold standard (test)medicine.diseaseTherapeutic approachBiopsymedicinebusinessAlgorithmePoster
researchProduct

P33 Up-regulation of FOXP3 T regulatory lymphocytes in patients with high-grade squamous intraepithelial lesions correlated with HPV infection

2019

Introduction/Background Regulatory (FOXP3+) T cells (Tregs) comprise a subpopulation of CD4+ T cells that suppress autoreactive immune cells, thereby protecting organs and tissues from autoimmunity. Novel therapeutic strategies for cervical cancer and squamous intraepithelial lesions (SIL) focus on immune-modulatory and cancer vaccination approaches. The aim of this study was to analyze the role of T regulatory cells (Tregs), CD4 and CD8 T lymphocytes and HPV status in low and high grade squamous intraepithelial lesions (LSIL and HSIL). Methodology 62 patients were enrolled in the study in Riga East University Hospital. Each patient had undergone a biopsy or electroexcision of the cervix. T…

Cervical cancermedicine.diagnostic_testbusiness.industryHPV infectionFOXP3medicine.diseaseKoilocyteImmune systemmedicine.anatomical_structureImmunologyBiopsymedicinebusinessCervixCD8Poster exhibition Day 1
researchProduct

343 External validation of tumour-free distance as novel prognostic marker in early-stage cervical cancer undergoing primary surgery

2020

Introduction Tumor-free distance (TFD), defined as the minimum distance of uninvolved stroma between the tumor and peri-cervical stromal ring, was recently proposed as predictive marker of recurrence in patients with early-stage cervical cancer treated by primary surgery (particularly if ≤3.5 mm). The aims of the present study were to assess the prognostic value of TFD and to compare TFD with other known prognostic markers in early-stage cervical cancer. Methods Patients with pathologic FIGO 2009 stage IA1-IIB cervical cancer, treated by primary radical surgical treatment between 01/2000 and 12/2018, were retrospectively included. Adjuvant treatment was administered according to the presenc…

Cervical cancermedicine.medical_specialtyMultivariate analysisPredictive markerHysterectomyParametrialbusiness.industrymedicine.medical_treatmentExternal validationmedicine.diseaseSurgeryLaparotomymedicineStage (cooking)businessPoster
researchProduct

Adaptive MR/CT Image-Guided Brachytherapy for Cervical Cancer Patients, With MRI Only at First Fraction

2011

Cervical cancermedicine.medical_specialtyOncologybusiness.industrymedicineImage guided brachytherapyRadiology Nuclear Medicine and imagingFraction (mathematics)Radiologymedicine.diseasebusinessBrachytherapy
researchProduct

336 Is a vaginectomy enough or is a pelvic exenteration always required for surgical treatment of recurrent cervical cancer?

2020

Introduction No consensus has yet been reached on the best strategy for treatment of cervical cancer local recurrence. Vaginectomy could be a salvage treatment in selected patients. Methods The records of vaginal recurrent cervical cancer patients admitted at Fondazione Policlinico ‘Agostino Gemelli’ IRCCS in Rome from January 2010 to June 2019 were retrospectively analyzed. We reported perioperative and survival outcomes of vaginectomy with respect to a matched series of pelvic exenteration (PE). Results Fifteen women underwent vaginectomy and 30 patients were submitted to PE. No statistical differences were observed between the two groups at baseline characteristics. The vaginectomy proce…

Cervical cancermedicine.medical_specialtyPelvic exenterationbusiness.industrymedicine.medical_treatmentRecurrent cervical cancerVaginectomyPerioperativemedicine.diseaseSurgeryRadiation therapyQuality of lifemedicinebusinessSurgical treatmentPoster
researchProduct

Is it time to broaden the scope of fertility-sparing treatments for early-stage cervical cancer?

2020

Cervical cancermedicine.medical_specialtyScope (project management)business.industrymedicine.medical_treatmentGeneral surgeryTrachelectomyMEDLINEConizationObstetrics and GynecologyUterine Cervical NeoplasmsTrachelectomyPilot Projectsmedicine.diseaseNeoadjuvant TherapyFertility sparing surgeryReproductive MedicinemedicineHumansFemaleStage (cooking)businessNeoadjuvant therapyFertility and sterility
researchProduct